U09.9 - Post COVID-19 condition, unspecified
- Applicable to Post COVID-19 condition, unspecified
- The 2025 edition of ICD10-CM U09.9 became effective on October 1, 2024.
- This is the American ICD10-CM version of U09.9 - other international versions of ICD10 U09.9 may differ.
- U09.9 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code Notes
- This code enables establishment of a link with COVID-19.
- This code is not to be used in cases that are still presenting with active COVID-19. However, an exception is made in cases of re-infection with COVID-19, occurring with a condition related to prior COVID-19.
Inclusion Term
- Post-acute sequela of COVID-19
codefirst
- the specific condition related to COVID-19 if known, such as:
- chronic respiratory failure (J96.1-)
- loss of smell (R43.8)
- loss of taste (R43.8)
- multisystem inflammatory syndrome (M35.81)
- pulmonary embolism (I26.-)
- pulmonary fibrosis (J84.10)
The following codes above U09.9 contain annotation back-references that may be applicable to U09.9:
Chapter: U00-U85 Codes for special purposes
Section: U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
Category: U09 Post COVID-19 condition
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com